BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 34638524)

  • 1. Complex Organ Construction from Human Pluripotent Stem Cells for Biological Research and Disease Modeling with New Emerging Techniques.
    Matsumoto R; Yamamoto T; Takahashi Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineering methods for vascularizing organoids.
    Nwokoye PN; Abilez OJ
    Cell Rep Methods; 2024 Jun; 4(6):100779. PubMed ID: 38759654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro generation of human pluripotent stem cell derived lung organoids.
    Dye BR; Hill DR; Ferguson MA; Tsai YH; Nagy MS; Dyal R; Wells JM; Mayhew CN; Nattiv R; Klein OD; White ES; Deutsch GH; Spence JR
    Elife; 2015 Mar; 4():. PubMed ID: 25803487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling endodermal organ development and diseases using human pluripotent stem cell-derived organoids.
    Pan FC; Evans T; Chen S
    J Mol Cell Biol; 2020 Aug; 12(8):580-592. PubMed ID: 32652003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hPSC-derived organoids: models of human development and disease.
    Frum T; Spence JR
    J Mol Med (Berl); 2021 Apr; 99(4):463-473. PubMed ID: 32857169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making a Kidney Organoid Using the Directed Differentiation of Human Pluripotent Stem Cells.
    Takasato M; Little MH
    Methods Mol Biol; 2017; 1597():195-206. PubMed ID: 28361319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system.
    Wang Y; Wang H; Deng P; Chen W; Guo Y; Tao T; Qin J
    Lab Chip; 2018 Dec; 18(23):3606-3616. PubMed ID: 30357207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional in vitro tissue culture models of brain organoids.
    Gong J; Meng T; Yang J; Hu N; Zhao H; Tian T
    Exp Neurol; 2021 May; 339():113619. PubMed ID: 33497645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond.
    Liu C; Oikonomopoulos A; Sayed N; Wu JC
    Development; 2018 Mar; 145(5):. PubMed ID: 29519889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single cell heterogeneity in human pluripotent stem cells.
    Yang S; Cho Y; Jang J
    BMB Rep; 2021 Oct; 54(10):505-515. PubMed ID: 34488931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D heterogeneous islet organoid generation from human embryonic stem cells using a novel engineered hydrogel platform.
    Candiello J; Grandhi TSP; Goh SK; Vaidya V; Lemmon-Kishi M; Eliato KR; Ros R; Kumta PN; Rege K; Banerjee I
    Biomaterials; 2018 Sep; 177():27-39. PubMed ID: 29883914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical look: Challenges in differentiating human pluripotent stem cells into desired cell types and organoids.
    Fowler JL; Ang LT; Loh KM
    Wiley Interdiscip Rev Dev Biol; 2020 May; 9(3):e368. PubMed ID: 31746148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney Organoids: A Translational Journey.
    Morizane R; Bonventre JV
    Trends Mol Med; 2017 Mar; 23(3):246-263. PubMed ID: 28188103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioengineering tissue morphogenesis and function in human neural organoids.
    Fedorchak NJ; Iyer N; Ashton RS
    Semin Cell Dev Biol; 2021 Mar; 111():52-59. PubMed ID: 32540123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AI-organoid integrated systems for biomedical studies and applications.
    Maramraju S; Kowalczewski A; Kaza A; Liu X; Singaraju JP; Albert MV; Ma Z; Yang H
    Bioeng Transl Med; 2024 Mar; 9(2):e10641. PubMed ID: 38435826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.
    Qian L; Tcw J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Three-Dimensional Bioengineering Technology to Generate Lung Tissue for Personalized Disease Modeling.
    Wilkinson DC; Alva-Ornelas JA; Sucre JM; Vijayaraj P; Durra A; Richardson W; Jonas SJ; Paul MK; Karumbayaram S; Dunn B; Gomperts BN
    Stem Cells Transl Med; 2017 Feb; 6(2):622-633. PubMed ID: 28191779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of hepatobiliary organoids from human induced pluripotent stem cells.
    Wu F; Wu D; Ren Y; Huang Y; Feng B; Zhao N; Zhang T; Chen X; Chen S; Xu A
    J Hepatol; 2019 Jun; 70(6):1145-1158. PubMed ID: 30630011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.